AJP - Regu Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 288: R919-R927, 2005. First published December 2, 2004; doi:10.1152/ajpregu.00744.2004
0363-6119/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/R919    most recent
00744.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, M. M.
Right arrow Articles by Samson, W. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, M. M.
Right arrow Articles by Samson, W. K.

NEUROHUMORAL CONTROL OF CARDIOVASCULAR FUNCTION

Intermedin/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake

Meghan M. Taylor, Sara L. Bagley, and Willis K. Samson

Department of Pharmacological and Physiological Science, Saint Louis University, St. Louis, Missouri

Submitted 3 November 2004 ; accepted in final form 25 November 2004

Intermedin (IMD)/adrenomedullin-2 (AM2) is a novel peptide that was independently discovered by two groups. The 47-amino acid peptide is homologous to adrenomedullin (AM) and can activate both the AM and calcitonin gene-related peptide (CGRP) receptors. IMD should therefore have actions similar to those of AM and CGRP. Indeed, like AM and CGRP, intravenous administration of IMD decreased blood pressure in rats and mice. We demonstrate here that immunoreactive IMD is present in plasma as well as heart, lung, stomach, kidney, pituitary, and brain. Because IMD is present in brain and both AM and CGRP have potent central nervous system (CNS) effects, we examined the ability of IMD within brain to regulate blood pressure and ingestive behaviors. Administration of IMD into the lateral cerebroventricle of rats caused significant, long-lasting elevations in mean arterial pressure and heart rate. These elevations are similar to the effects of CGRP and significantly greater than the effects of AM. IMD-induced elevations in mean arterial pressure were inhibited by intravenous administration of phentolamine, indicating that IMD activates the sympathetic nervous system. Intracerebroventricular administration of IMD also inhibited food and water intake in sated and in food- and water-restricted animals. The effects on feeding are likely related to activation of the CGRP receptor and are independent of the effects on water intake, which are likely through the AM receptor. Our data indicate that IMD has potent actions within the CNS that may be a result of the combined activation of both AM and CGRP receptors.

calcitonin gene-related peptide; heart rate; brain


Address for reprint requests and other correspondence: M. M. Taylor, Dept. of Pharmacological and Physiological Science, Saint Louis Univ., 1402 South Grand Boulevard, St. Louis, MO 63104 (E-mail: taylormm{at}slu.edu)




This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Ogoshi, S. Nobata, and Y. Takei
Potent osmoregulatory actions of homologous adrenomedullins administered peripherally and centrally in eels
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R2075 - R2083.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. K. Samson, J. V. Zhang, O. Avsian-Kretchmer, K. Cui, G. L. C. Yosten, C. Klein, R.-M. Lyu, Y. X. Wang, X. Q. Chen, J. Yang, et al.
Neuronostatin Encoded by the Somatostatin Gene Regulates Neuronal, Cardiovascular, and Metabolic Functions
J. Biol. Chem., November 14, 2008; 283(46): 31949 - 31959.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. K. Samson, M. M. White, C. Price, and A. V. Ferguson
Obestatin acts in brain to inhibit thirst
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R637 - R643.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
M. Chauhan, U. Yallampalli, L. Reed, and C. Yallampalli
Adrenomedullin 2 Antagonist Infusion to Rats During Midgestation Causes Fetoplacental Growth Restriction Through Apoptosis
Biol Reprod, December 1, 2006; 75(6): 940 - 947.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
F. Dong, M. M. Taylor, W. K. Samson, and J. Ren
Intermedin (adrenomedullin-2) enhances cardiac contractile function via a protein kinase C- and protein kinase A-dependent pathway in murine ventricular myocytes
J Appl Physiol, September 1, 2006; 101(3): 778 - 784.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Fujisawa, Y. Nagai, A. Miyatake, K. Miura, T. Shokoji, A. Nishiyama, S. Kimura, and Y. Abe
Roles of adrenomedullin 2 in regulating the cardiovascular and sympathetic nervous systems in conscious rats
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1120 - H1127.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. Hashimoto, S. Hyodo, M. Kawasaki, T. Mera, L. Chen, A. Soya, T. Saito, H. Fujihara, T. Higuchi, Y. Takei, et al.
Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E753 - E761.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.